Drug Development and Industrial Pharmacy
 | |
Abbreviated title (ISO 4) | Drug Dev Ind Pharm |
|---|---|
| Discipline | Pharmaceutical Science |
| Language | English |
| Edited by | Robert O. Williams III |
| Publication details | |
| Publisher |
Informa Pharmaceutical Science |
| No | |
| 2.101 | |
| Indexing | |
| ISSN |
0363-9045 (print) 1520-5762 (web) |
| Links | |
Drug Development and Industrial Pharmacy is an academic journal that publishes research on aspects of drug development and production, as well as the evaluation of drugs and pharmaceutical products.
Core Areas
Topics covered include:
- Emerging technologies in pharmaceutical development and industrial pharmacy
- In vitro–In vivo correlations
- Oral controlled release systems
- Drug delivery
- Preclinical drug development, pharmacokinetics and pharmacodynamics
- Drug pharmacokinetics and pharmacodynamics
- Biopharmaceutics and oral absorption
- Aerosols
- Transdermals
- Preformulation and physical pharmacy
- Methodologies, including statistical design/optimisation, if there is clear clinical relevance.
The journal is owned by Informa plc, a United Kingdom-based publisher and conference company.
Editor
Hugh D. Smyth, Ph.D.is Editor-in-Chief .[1] He is has the Delgado Endowed Professorship at the College of Pharmacy, University of Texas at Austin.[2]
Publication Format
The journal publishes 12 issues per year in simultaneous print and online editions and is available on a subscription basis. Individual articles can be purchased on a pay-per-view basis. All back-issues of the journal are available online and are hosted on the publisher's website.
Subscribers to the electronic edition of 'the journal receive access to the online archive, which dates back to 1974.[3]
References
- ↑ "Editorial Board Members". informapharmascience.com. Retrieved 2009-05-22.
- ↑ "University of Texas at Austin". www.utexas.edu. Retrieved 2009-06-10.
- ↑ "Informa Pharmaceutical Science brochure". informapharmascience.com. Retrieved 2009-05-22.